Oculis Holding AG (OCS) Change in Cash (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Change in Cash of -$22.0 million in Q1 2026, down 150.45% quarter-over-quarter from $43.7 million in Q4 2025, and down 159.36% on a YoY basis from $37.1 million in Q1 2025.
Oculis Holding AG (OCS) Change in Cash (2022 - 2026) Analysis & Trends
Oculis Holding AG's Change in Cash history runs 5 years deep, the most recent figure standing at -$22.0 million for Q1 2026.
- In Q1 2026, Change in Cash fell 159.36% year-over-year to -$22.0 million; the TTM figure through Mar 2026 stood at $10.5 million (down 74.29% YoY), while the FY2025 annual figure was $74.7 million, up 693.26% from the prior year.
- Change in Cash was -$22.0 million for Q1 2026 at Oculis Holding AG, down from $43.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $86.1 million in Q1 2023 to a low of -$57.7 million in Q2 2023.
- Historically, Change in Cash has averaged $2.8 million across 5 years, with a median of -$8.1 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 205.76% in 2023, then soared 536.38% in 2025.
- A 5-year view of Change in Cash shows it stood at -$8.6 million in 2022, then jumped by 219.37% to $10.3 million in 2023, then slumped by 196.97% to -$10.0 million in 2024, then jumped by 536.38% to $43.7 million in 2025, then plunged by 150.45% to -$22.0 million in 2026.
- The last three Change in Cash figures came in at -$22.0 million (Q1 2026), $43.7 million (Q4 2025), and -$22.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -45.97 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | -22.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.03 Mn |
| Dec 31, 2025 | 43.66 Mn |
| Sep 30, 2025 | -22.16 Mn |
| Jun 30, 2025 | 11.04 Mn |
| Mar 31, 2025 | 37.11 Mn |
| Dec 31, 2024 | -10.01 Mn |
| Sep 30, 2024 | -8.06 Mn |
| Jun 30, 2024 | 21.88 Mn |
| Mar 31, 2024 | -17.26 Mn |
| Dec 31, 2023 | 10.32 Mn |
| Sep 30, 2023 | -17.36 Mn |
| Jun 30, 2023 | -57.67 Mn |
| Mar 31, 2023 | 86.12 Mn |
| Dec 31, 2022 | -8.64 Mn |
| Sep 30, 2022 | -5.68 Mn |